ICU Stock Analysis: Buy, Sell, or Hold?
ICU - SeaStar Medical Holding Corporation Common Stock
$3.20
0.06 (2.08%)
▲
5d:
-10.5%
30d:
-35.06%
90d:
-26.89%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
7d
Get Alerted When ICU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ICU is down 10.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ICU is down 10.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ICU is currently trading at $3.19, which is considered oversold relative to its 30-day fair value range of $3.40 to $4.77.
Technical Outlook: Technically, ICU is in a downtrend. Immediate support is located at $3.06, while resistance sits at $4.04.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+213.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ICU is in a downtrend. Immediate support is located at $3.06, while resistance sits at $4.04.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+213.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.40 -
$4.77
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 213.0% below Wall St target ($10.00)
- WARNING: Recommendation downgraded due to -10.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$3.40 -
$4.77
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.06
Resistance Level
$4.04
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.37
Wall Street Target
$10.00
(+213.0%)
Revenue Growth (YoY)
68.9%
Share & Embed Analysis
Last updated: August 04, 2026 4:47 AM ET
Data refreshes hourly during market hours. Next update: 5:47 AM
Data refreshes hourly during market hours. Next update: 5:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1080 | 57 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 54 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 59 HOLD |
